Russian Medical Inquiry · 2021 · 16 citations · 18 references
Life SciencesImmunologyInfectious DiseasesClinical ImmunologyImmunopathologyInflammationAutoimmune Disease PathogenesisAutoimmune DiseasesDiagnostic ImmunologyImmune-mediated DiseaseImmune-mediated Inflammatory DiseasesImmunopathology Of Infectious DiseasesC-reactive Protein TestingCholinesterase BiomarkersDisease Severity CorrelationsImmune MarkersImmunological MechanismsImmunological ResponseNeutrophil-to-lymphocyte RatioPlatelet-to-lymphocyte Ratio
The article presents the conducted analysis of risk factors, immunological mechanisms and biological markers of the severe COVID-19 course. Official statistical data and scientific publications on the problem of assessing the risk of severe COVID-19 course were used in this analysis. It was found that elderly age, male gender, the presence of comorbidity (diabetes mellitus, cardiovascular, respiratory, renal and autoimmune diseases, and immunodeficiency conditions) increase the risk of an adverse outcome in COVID-19. The following immunological mechanisms of the disease manifestation and prognostic significance of different biological markers were determined: elevated levels of SAA, C-reactive protein, procalcitonin, IL-6, urea, creatinine, direct bilirubin, LDH, D-dimer and serum cholinesterase. Lymphopenia (abnormally low level of lymphocytes) and neutrophil-to-lymphocyte ratio (NLR) are the most common described prognostic markers in COVID-19. Thrombocytopenia and elevated D-dimer levels may indicate coagulopathies in patients with COVID-19 and predict morbidity and mortality even at the onset. Thus, the determination of risk factors and levels of inflammatory markers (commonly found in severe cases of COVID-19) should be used to choose the right treatment tactics to improve the clinical outcome. KEYWORDS: COVID-19, risk factors, immunological mechanisms, comorbidity, biological markers. FOR CITATION: Bilichenko T.N. Risk factors, immunological mechanisms and biological markers of severe COVID-19 course (study overview). Russian Medical Inquiry. 2021;5(5):237–244 (in Russ.). DOI: 10.32364/2587-6821-2021-5-5-237-244.
18
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta, Daniel F. McAuley, Michael Brown et al. · The Lancet · 2020 · 10.2K citations · Full text
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth Williamson, Alex J Walker, Krishnan Bhaskaran et al. · Nature · 2020 · 6.7K citations · Full text
Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +6